Serum Platelet-Derived Growth Factor Is Significantly Lower in Patients with Lung Cancer and Continued to Decrease After Platinum-Based Chemotherapy.

Rong MaQing YangShengya CaoSiwen LiuHaixia CaoHeng XuJianzhong WuJi-Feng Feng

Published in: OncoTargets and therapy (2020)

Serum PDGF may be a potential biomarker for diagnosis of patients with NSCLC and SCLC. However, the prognostic value of serum PDGF in patients with NSCLC harboring mutations and different therapies requires additional investigation.

Keyphrases

growth factor
small cell lung cancer
advanced non small cell lung cancer
smooth muscle
squamous cell carcinoma
radiation therapy
epidermal growth factor receptor
angiotensin ii